Author Archive
Delayed deaths declining among pediatric cancer survivors
By Gene Emery It's long been known that cancer survivors -- people alive five years after diagnosis -- face a higher risk of premature death, and doctors have made efforts over the decades to reduce those
Task force: Mammograms an option at 40, do more good at 50
WASHINGTON (AP) — Mammograms do the most good later in life, a government task force declared Monday in recommending that women get one every other year starting at age 50. It said 40-somethings should make their
‘Projectile’ hits Medecins Sans Frontieres clinic in Yemen, killing four: MSF
A "projectile" struck a clinic supported by international medical group Medecins Sans Frontieres in north Yemen on Sunday, killing four people, MSF said, another in a series of attacks on its facilities in the war-torn country. MSF
New U.S. diet rule gets mixed response on social media
Hashtag #DietaryGuidelines was among the top trending topics on Twitter after U.S. government released a report late on Thursday suggesting people should keep their sugar and corn syrup intake to less than 10 percent of daily
New U.S. cancer cases holding steady, deaths declining
By Andrew M. Seaman The number of new cancer diagnoses in the U.S. is largely steady while the number of cancer deaths continues to decline, according to a new report from the nation's leading cancer advocacy
Valeant to appoint interim CEO as Pearson remains hospitalized: source
By Sneha Banerjee and Carl O'Donnell (Reuters) - Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that
Conatus liver drug shows promise in mid-stage trial
(Reuters) - Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment,
Valeant plans to appoint new CEO as Pearson remains hospitalized: WSJ
(Reuters) - Valeant Pharmaceuticals International Inc is planning to appoint a new CEO as Chief Executive Michael Pearson remains hospitalized, the Wall Street Journal said, citing people familiar with the matter. The new chief executive would
Execution of Saudi cleric latest blow to hopes of rapprochement with Iran
By Sam Wilkin DUBAI (Reuters) - Iranian clerics, officials and students attacked Sunni Muslim-ruled Saudi Arabia on Saturday for executing Shi'ite cleric Nimr al-Nimr, a move that seemed to further doom any hope of rapprochement between two
China December factory activity shrinks, more stimulus needed in 2016
China looked set for a soggy start to 2016 after activity in the manufacturing sector contracted for a fifth straight month in December, suggesting the government may have to step up policy support to avert a